Found 59 matching trials
The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers PHASE1 The purpose of this study is to examine the effect of buprenorphine on QT i...
Show More Location
PPD Development, LP, Clinics
Learn More & Join Trial
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain PHASE3 The objective of this study is to demonstrate the effectiveness and tolerab...
Show More Location
Hawthorne and York
Learn More & Join Trial
Estrogen, Diabetes, and Endothelial Function NA This study planned to learn more about women and how the drop in estradiol ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model PHASE2 Narcotics are widely used as the mainstay of pain treatment, although incre...
Show More Location
School of Dental Medicine At East Carolina University
Learn More & Join Trial
A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days PHASE1 This study will evaluate the steady-state pharmacokinetics, safety and tole...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole PHASE1 The purpose of this study is to assess the pharmacokinetics of buprenorphin...
Show More Location
Clinical Research Center
Learn More & Join Trial
Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch PHASE1 This study is intended to produce information on the pharmacokinetic charac...
Show More Location
Swiss Pharma Contract
Learn More & Join Trial
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients PHASE3 The primary objective of this study was to demonstrate that Rotigotine tran...
Show More Learn More & Join Trial
CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease) PHASE3 Parkinson's disease is a common condition particularly affecting older peop...
Show More Location
Barking, Havering and Redbridge University Hospitals NHS trust
Learn More & Join Trial
Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy PHASE4 This trial is being conducted to assess the effects of Rotigotine over Plac...
Show More Learn More & Join Trial